129 related articles for article (PubMed ID: 1425774)
1. Immunolocalization of secretogranin II, chromogranin A, and chromogranin B in differentiating human neuroblastoma cells.
Giudici AM; Sher E; Pelagi M; Clementi F; Zanini A
Eur J Cell Biol; 1992 Aug; 58(2):383-9. PubMed ID: 1425774
[TBL] [Abstract][Full Text] [Related]
2. Aspects of the neuroendocrine cerebellum: expression of secretogranin II, chromogranin A and chromogranin B in mouse cerebellar unipolar brush cells.
Nunzi MG; Mugnaini E
Neuroscience; 2009 Sep; 162(3):673-87. PubMed ID: 19217926
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of secretogranin II and chromogranin B by cyclic AMP in a rat pheochromocytoma cell line.
Thompson ME; Valentine DL; Strada SJ; Wagner JA; Scammell JG
Mol Pharmacol; 1994 Nov; 46(5):880-9. PubMed ID: 7969075
[TBL] [Abstract][Full Text] [Related]
4. Chromogranin A, chromogranin B and secretogranin II mRNAs in the pituitary and adrenal glands of various mammals. Regulation of chromogranin A, chromogranin B and secretogranin II mRNA levels by estrogen.
Lloyd RV; Hawkins K; Jin L; Kulig E; Fields K
Lab Invest; 1992 Sep; 67(3):394-404. PubMed ID: 1405495
[TBL] [Abstract][Full Text] [Related]
5. Immunolocalization of secretogranin II and insulin in a nerve growth factor-differentiated insulinoma cell line.
Sher E; Rosa P; Bassetti M; Zanini A
Eur J Cell Biol; 1995 May; 67(1):15-22. PubMed ID: 7641727
[TBL] [Abstract][Full Text] [Related]
6. Secretogranin II expression in Ewing's sarcomas and primitive neuroectodermal tumors.
Pagani A; Fischer-Colbrie R; Sanfilippo B; Winkler H; Cerrato M; Bussolati G
Diagn Mol Pathol; 1992 Sep; 1(3):165-72. PubMed ID: 1342962
[TBL] [Abstract][Full Text] [Related]
7. Secretogranin III in human neuroendocrine tumours: a comparative immunohistochemical study with chromogranins A and B and secretogranin II.
Portela-Gomes GM; Grimelius L; Stridsberg M
Regul Pept; 2010 Nov; 165(1):30-5. PubMed ID: 20550951
[TBL] [Abstract][Full Text] [Related]
8. Chromogranins A and B and secretogranin II as prohormones for regulatory peptides from the diffuse neuroendocrine system.
Helle KB
Results Probl Cell Differ; 2010; 50():21-44. PubMed ID: 20217490
[TBL] [Abstract][Full Text] [Related]
9. Presence of chromogranins and regulation of their synthesis and processing in a neuroendocrine prostate tumor cell line.
Ischia R; Culig Z; Eder U; Bartsch G; Winkler H; Fischer-Colbrie R; Klocker H
Prostate Suppl; 1998; 8():80-7. PubMed ID: 9690667
[TBL] [Abstract][Full Text] [Related]
10. Differential expression and processing of chromogranin A and secretogranin II in relation to the secretory status of endocrine cells.
Peinado JR; Vazquez-Martinez R; Cruz-García D; Ruiz-Navarro A; Anouar Y; Tonon MC; Vaudry H; Gracia-Navarro F; Castano JP; Malagón MM
Endocrinology; 2006 Mar; 147(3):1408-18. PubMed ID: 16357044
[TBL] [Abstract][Full Text] [Related]
11. Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin.
Gazdar AF; Helman LJ; Israel MA; Russell EK; Linnoila RI; Mulshine JL; Schuller HM; Park JG
Cancer Res; 1988 Jul; 48(14):4078-82. PubMed ID: 3383200
[TBL] [Abstract][Full Text] [Related]
12. Different expression of chromogranin A and chromogranin B in various types of pituitary adenomas.
Riva C; Leutner M; Capella C; Usellini L; la Rosa S; Brianza MR; Buffa R
Zentralbl Pathol; 1993 Jun; 139(2):165-70. PubMed ID: 8396420
[TBL] [Abstract][Full Text] [Related]
13. Immunoreactivities for chromogranin A and B, and secretogranin II in the guinea pig entero-endocrine system: cellular distributions and intercellular heterogeneities.
Cetin Y; Grube D
Cell Tissue Res; 1991 May; 264(2):231-41. PubMed ID: 1878943
[TBL] [Abstract][Full Text] [Related]
14. Regulation of chromogranin biosynthesis by neurotrophic growth factors in neuroblastoma cells.
Weiss C; Winkler H; Laslop A
Neurochem Int; 2001 Jan; 38(1):43-52. PubMed ID: 10913687
[TBL] [Abstract][Full Text] [Related]
15. Participation of type II protein kinase A in the retinoic acid-induced growth inhibition of SH-SY5Y human neuroblastoma cells.
Kim SN; Kim SG; Park SD; Cho-Chung YS; Hong SH
J Cell Physiol; 2000 Mar; 182(3):421-8. PubMed ID: 10653609
[TBL] [Abstract][Full Text] [Related]
16. Secretogranin II: a key AP-1-regulated protein that mediates neuronal differentiation and protection from nitric oxide-induced apoptosis of neuroblastoma cells.
Li L; Hung AC; Porter AG
Cell Death Differ; 2008 May; 15(5):879-88. PubMed ID: 18239671
[TBL] [Abstract][Full Text] [Related]
17. Presence of secretogranin II and high-capacity, low-affinity Ca2+ storage role in nucleoplasmic Ca2+ store vesicles.
Yoo SH; Chu SY; Kim KD; Huh YH
Biochemistry; 2007 Dec; 46(50):14663-71. PubMed ID: 18020452
[TBL] [Abstract][Full Text] [Related]
18. Effects of estrogen and dexamethasone on a transgenic pituitary cell line. Regulation of hormone and chromogranin/secretogranin expression.
Thiny MT; Antczak C; Fields K; Jin L; Lloyd RV
Lab Invest; 1994 Jun; 70(6):899-906. PubMed ID: 7912292
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical demonstration of chromogranin A, chromogranin B, and secretogranin II in extra-adrenal paragangliomas.
Schmid KW; Schröder S; Dockhorn-Dworniczak B; Kirchmair R; Tötsch M; Böcker W; Fischer-Colbrie R
Mod Pathol; 1994 Apr; 7(3):347-53. PubMed ID: 8058707
[TBL] [Abstract][Full Text] [Related]
20. Prolactin and secretogranin-II, a marker for the regulated pathway, are secreted in parallel by pituitary GH4C1 cells.
Hinkle PM; Scammell JG; Shanshala ED
Endocrinology; 1992 Jun; 130(6):3503-11. PubMed ID: 1597152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
